Candriam SCA’s AB InBev BUD Stock Holding History

Candriam SCA’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,500	Closed	-$296K	–	796
2018 Q4	$296K	Buy	+4,500	New	+$344K	﹤0.01%	747

Other funds holding BUD

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Candriam SCA's BUD Position: Q1 2019 in Review

Candriam SCA sold out of AB InBev (BUD) in Q1 2019, closing a stake of 4,500 shares — an estimated $296K sold.

Candriam SCA first reported a position in BUD in Q4 2018 and held it in 1 quarter. The position peaked at $296K in Q4 2018. 525 funds tracked by Wall St. Rank hold BUD as of Q1 2019.

Candriam SCA reported no remaining AB InBev position as of Q1 2019 after selling out during the quarter.
Candriam SCA sold 4,500 AB InBev shares in Q1 2019, an estimated $296K.
Candriam SCA first reported a position in AB InBev in Q4 2018 and held it in 1 quarter.
Candriam SCA's AB InBev position peaked at $296K in Q4 2018.
525 funds tracked by Wall St. Rank held AB InBev as of Q1 2019.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.